France· FR:64208131
RIFATER, comprimé enrobé
A medicinal product containing rifampicine + isoniazide + pyrazinamide, registered in France by SANOFI WINTHROP INDUSTRIE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- RIFAMPICINE + ISONIAZIDE + PYRAZINAMIDE
- Manufacturer
- SANOFI WINTHROP INDUSTRIE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400932993536plaquette(s) thermoformée(s) PVC-Aluminium PVDC de 60 comprimé(s)EUR 20.74
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rifampicine + isoniazide + pyrazinamide in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomRifater tabletsDrugsrus Ltd
- NorwayRifaterSanofi-aventis
- SpainRIFATER COMPRIMIDOS RECUBIERTOSSanofi Aventis S.A.
- FinlandRimcureSandoz A/S
- IrelandRifater 50 mg/300 mg/120 mg TabletsSanofi-Aventis Ireland Limited T/A SANOFI
- SwitzerlandRifater, comprimés enrobésSanofi-Aventis (Suisse) SA
- SwedenRimcure 150 mg/75 mg/400 mg Filmdragerad tablettSandoz A/S
- CzechiaRIFAMPICIN 75MG + ISONIAZID 50MG + PYRAZINAMIDE 150MG
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Spain · Rifater
- United Kingdom (Northern Ireland) · Rifater
- Ireland · Rifater
- Italy · Rifater
- Norway · Rimcure
- Portugal · Rifater
- Sweden · Rimcure
- Slovenia · Rifater
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5e660ca4-842e-4200-958f-7726b10d7903 GET /v1/drugs/5e660ca4-842e-4200-958f-7726b10d7903?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64208131",
"date_amm": "1987-10-09",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "RIFAMPICINE + ISONIAZIDE + PYRAZINAMIDE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé enrobé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about rifampicine + isoniazide + pyrazinamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.